{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:26:48Z","timestamp":1794493608666,"version":"4.9.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000902","name":"Translation Centre for the Bodies of the European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.xcrm.2024.101803","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T14:35:48Z","timestamp":1730126148000},"page":"101803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Integrative single-cell multi-omics of CD19-CARpos and CARneg T\u00a0cells suggest drivers of immunotherapy response in B cell neoplasias"],"prefix":"10.1016","volume":"5","author":[{"given":"Mercedes","family":"Guerrero-Murillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Rill-Hinarejos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L.","family":"Trincado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valent\u00edn","family":"Ortiz-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ben\u00edtez-Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Espa\u00f1ol-Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Azucena","family":"Gonz\u00e1lez-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Mart\u00ednez-Cibri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dom\u00e9nica","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Mart\u00edn-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00edn Garc\u00eda-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Rives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Urbano-Ispiz\u00faa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Mereu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101803_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0140-6736(21)00933-8","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b\/2 open-label study","volume":"398","author":"Berdeja","year":"2021","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.xcrm.2024.101803_bib2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19-28z CAR T\u00a0cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib4","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T\u00a0cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101803_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib6","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib8","article-title":"Factors associated with the clinical outcome of patients with relapsed\/refractory CD19 + acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy","volume":"9","author":"Ortiz-Maldonado","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2024.101803_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2022.02.001","article-title":"Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned","volume":"108","author":"Can","year":"2022","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.xcrm.2024.101803_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0514","article-title":"CAR density influences antitumoral efficacy of BCMA CAR T\u00a0cells and correlates with clinical outcome","volume":"8","author":"Rodriguez-Marquez","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101803_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T\u00a0cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101803_bib12","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1158\/0008-5472.CAN-06-0160","article-title":"CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in\u00a0vivo persistence and antitumor efficacy of adoptively transferred T\u00a0cells","volume":"66","author":"Kowolik","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101803_bib13","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR\u2013T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101803_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/leu.2015.247","article-title":"Chimeric antigen receptor-modified T\u00a0cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in\u00a0vivo","volume":"30","author":"Sommermeyer","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101803_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2024.101803_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T\u00a0cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101803_bib17","article-title":"Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T\u00a0cells","volume":"9","author":"Bai","year":"2021","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2024.101803_bib18","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1158\/2159-8290.CD-21-1508","article-title":"Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages","volume":"12","author":"Wilson","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101803_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","article-title":"Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy","volume":"11","author":"Sheih","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101803_bib20","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/2159-8290.CD-21-1586","article-title":"Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma","volume":"12","author":"Jackson","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101803_bib21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","article-title":"Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma","volume":"28","author":"Haradhvala","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41467-021-21168-6","article-title":"Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy","volume":"12","author":"Rabilloud","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101803_bib23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ymthe.2020.09.027","article-title":"CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed\/Refractory Malignancies","volume":"29","author":"Ort\u00edz-Maldonado","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2024.101803_bib24","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1182\/blood-2022-166297","article-title":"Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and\/or Refractory B Cell Malignancies (IMAGINE Study)","volume":"140","author":"Damodar","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101803_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fimmu.2020.00482","article-title":"Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial","volume":"11","author":"Castella","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib26","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/eji.200526122","article-title":"Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T\u00a0cell differentiation in peripheral blood","volume":"35","author":"Bratke","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib27","first-page":"538","article-title":"Understanding CAR T\u00a0cell-tumor interactions: Paving the way for successful clinical outcomes","volume":"3","author":"Korell","year":"2022","journal-title":"M\u00e9d."},{"key":"10.1016\/j.xcrm.2024.101803_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2643-3230.BCD-23-0212","article-title":"Understanding Mechanisms of Response to CAR T-cell Therapy through Single-Cell Sequencing: Insights and Challenges","volume":"5","author":"Haradhvala","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101803_bib29","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.it.2021.09.004","article-title":"Staggered starts in the race to T\u00a0cell activation","volume":"42","author":"Richard","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib30","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3390\/jcm9113577","article-title":"CAR T-Cells in Multiple Myeloma Are Ready for Prime Time","volume":"9","author":"Rodr\u00edguez-Otero","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib31","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1182\/bloodadvances.2020002394","article-title":"Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Locke","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2024.101803_bib32","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1038\/s41467-022-30860-0","article-title":"A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T\u00a0cell expansion, persistence, and anti-tumor activity","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101803_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.omtm.2018.11.010","article-title":"Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions","volume":"12","author":"Castella","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2024.101803_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1866287","article-title":"Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signatures","volume":"10","author":"Wang","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2024.101803_bib35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjh.19117","article-title":"The CD4\/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity","volume":"203","author":"Galli","year":"2023","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2024.101803_bib36","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.19.03279","article-title":"CD4\/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial","volume":"38","author":"Shah","year":"2020","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101803_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T\u00a0cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2024.101803_bib38","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/imm.13642","article-title":"T-cell exhaustion in CAR-T-cell therapy and strategies to overcome it","volume":"169","author":"Yin","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.xcrm.2024.101803_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-023-01504-7","article-title":"Reprogramming T\u00a0cell differentiation and exhaustion in CAR-T cell therapy","volume":"16","author":"Bulliard","year":"2023","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2024.101803_bib40","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T\u00a0cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101803_bib41","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/ijms25042416","article-title":"Harnessing the Transcriptional Signatures of CAR-T-Cells and Leukemia\/Lymphoma Using Single-Cell Sequencing Technologies","volume":"25","author":"Liao","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2024.101803_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-024-01065-z","article-title":"Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients","volume":"14","author":"Mart\u00edn-Mart\u00edn","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2024.101803_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fimmu.2015.00020","article-title":"\u03b3\u03b4 T Lymphocytes in the Diagnosis of Human T Cell Receptor Immunodeficiencies","volume":"6","author":"Garcill\u00e1n","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jhep.2018.05.007","article-title":"Human liver infiltrating \u03b3\u03b4 T\u00a0cells are composed of clonally expanded circulating and tissue-resident populations","volume":"69","author":"Hunter","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.xcrm.2024.101803_bib45","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of \u03b3\u03b4 T\u00a0cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101803_bib46","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1038\/s41467-023-43656-7","article-title":"CAR+ and CAR\u2212 T\u00a0cells share a differentiation trajectory into an NK-like subset after CD19 CAR T\u00a0cell infusion in patients with B cell malignancies","volume":"14","author":"Louie","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101803_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01347","article-title":"Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia","volume":"11","author":"Rozenbaum","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3120","article-title":"Cord blood\u2013derived V \u03b4 2 + and V \u03b4 2 \u2212 T\u00a0cells acquire differential cell state compositions upon in\u00a0vitro expansion","volume":"9","author":"Ng","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2024.101803_bib49","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101803_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2024.101803_bib51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2024.101803_bib52","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2024.101803_bib53","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive Integration of Single-Cell Data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101803_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2024.101803_bib55","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","article-title":"Pan-cancer T\u00a0cell atlas links a cellular stress response state to immunotherapy resistance","volume":"29","author":"Chu","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101803_bib56","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1737369","article-title":"Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq","volume":"9","author":"Carmona","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2024.101803_bib57","article-title":"Robust differential composition and variability analysis for multisample cell omics","author":"Mangiola","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2024.101803_bib58","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2024.101803_bib59","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2024.101803_bib60","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","article-title":"UCell: Robust and scalable single-cell gene signature scoring","volume":"19","author":"Andreatta","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2024.101803_bib61","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101803_bib62","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2024.101803_bib63","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.molonc.2015.09.003","article-title":"T-cell receptor profiling in cancer","volume":"9","author":"Kirsch","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.xcrm.2024.101803_bib64","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101803_bib65","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T\u00a0cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101803_bib66","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2024.101803_bib67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","article-title":"Peripheral T\u00a0cell expansion predicts tumour infiltration and clinical response","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1016\/j.xcrm.2025.102026","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000}}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124005500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124005500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T04:11:26Z","timestamp":1758687086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124005500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2666379124005500"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101803","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative single-cell multi-omics of CD19-CARpos and CARneg T\u00a0cells suggest drivers of immunotherapy response in B cell neoplasias","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101803"}}